KIYATEC

Recent Finacing

Equity

Recent Raise

Undisclosed

Kiyatec develops and operates a proprietary ex vivo 3D cell‑culture platform and CLIA‑certified lab to provide functional precision oncology assays (3D‑Predict) and preclinical drug‑response services for solid tumors.

Founded 2005

South Carolina, United States

11-50

Private

kiyatec.com

Highlights

Focus Areas

Biotechnology

Health Diagnostics

Life Science

Recent Investors

G

Financials

$22.5M

Total Raised

8

Funding rounds

11

Investors

Team

Upgrade to view the team

See the team members at KIYATEC.